A story on Titan Pharmaceuticals Inc. published in the July 25, 2001, issue of BioWorld Today incorrectly reported that Lazard Freres & Co. LLC downgraded Titan¿s stock. Lazard Freres maintained its buy rating.

Editor¿s Note: The correction has been made in BioWorld Online.